What is Smaio?
Founded in 2009 and headquartered in France, Smaio is a key player in the medical manufacturing sector, focusing on innovative vertebral fusion technology. The company designs and produces advanced solutions for spinal surgery and treatment, catering to business clients within the European healthcare industry. Smaio's commitment to developing cutting-edge medical devices positions it as a significant contributor to patient care and surgical advancement.
How much funding has Smaio raised?
Smaio has raised a total of $2.7M across 1 funding round:
Other Financing Round
$2.7M
Other Financing Round (2023): $2.7M with participation from Bpifrance
Key Investors in Smaio
Bpifrance
Bpifrance is a French public investment bank that finances companies at all stages of development, supporting them with credit, guarantees, and equity. They also assist with innovation projects, international expansion, and export activities, offering consulting and acceleration programs for businesses.
What's next for Smaio?
The recent major enterprise-level funding indicates Smaio is likely in a growth or scaling phase, poised to expand its market reach and further develop its innovative spinal fusion technologies. This strategic investment will likely fuel research and development, enhance manufacturing capabilities, and potentially broaden its European footprint. The company's focus on specialized medical technology suggests a trajectory aimed at solidifying its position as a leader in the vertebral fusion market.
See full Smaio company page
